Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Fortis Malar Hospitals Ltd (FORTISMLR) Share Price & Fundamentals

Company Overview

Founded Year

1989

Listed Year

-

Headquarter

Chennai, India

MD/CEO

Dr. K M Cherian, renowned cardiac surgeon and Padmashree awardee, led Cardio Thoracic services.

Website

http://www.fortismalarhospital.com

Company Facts

What we do

Fortis Malar Hospitals Ltd operated a multi-specialty hospital in Chennai, providing premium healthcare services in cardiology, neurology, and other specialities until sale of operations in 2024.

Founded in

1,989

Market share

Recognized as one of the largest corporate hospitals in Chennai with significant presence in cardiac and tertiary care markets.

Problem solved

Addressed critical healthcare needs including cardiac surgeries, neuro surgery, orthopedics and multi-specialty medical care.

Top clients or who we serve

Served diverse patient base requiring multi-specialty hospital services across individual patients and referring physicians (B2C).

Key management

Dr. K M Cherian, renowned cardiac surgeon and Padmashree awardee, led Cardio Thoracic services.

Our journey and innovations

Established in 1989; pioneered open heart surgeries since 2003; expanded capacity and services; sold hospital operations in 2024.

Where we operate

Operated primarily in Chennai, Tamil Nadu, India.

Top products or what we offer

Hospital services in Cardiology, Neuro Surgery, Gynecology, Orthopedics, Gastroenterology, Pediatrics, Nephrology, Internal Medicine.

Top brands

Fortis Malar Hospital: #1 multi-specialty hospital in Chennai, key revenue driver till 2024.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenues were largely service-based and recurring through patient treatments until operations ceased.

Our industry position

Strong leader in Chennai's healthcare market with specialty focus; ceased operations in 2024 post asset sale.

Financial highlights

FY 2024-25 consolidated revenue stood near zero post sale; prior year revenue Rs. 59 crore; FY25 profit Rs. 0.39 crore after exceptional items.

Geographical revenue split

Revenue primarily from Chennai region, India.

Order book

-

Whats driving growth

Earlier growth driven by specialty healthcare demand and pioneering surgeries; no current operations post divestment.

Our future plans

Evaluating corporate restructuring and no current visibility of new business operations.

Our green promise

-

Our people and values

Previously employed healthcare professionals; no employees as on March 31, 2025 post divestment.

Key challenges ahead

Transitioned from active operations; main challenges include restructuring and future business strategy development.

Interesting facts

Performed 26,200 cardio thoracic surgeries under Dr. K M Cherian including transplants; hospital operated over 35 years.

Risks and strategy

Risks relate to corporate restructuring post divestment; strategy focuses on asset management and shareholder returns.

Market Footprint

Top Clients

Top Clients

Served diverse patient base requiring multi-specialty hospital services across individual patients and referring physicians (B2C).

Top Products

Top Products

Hospital services in Cardiology, Neuro Surgery, Gynecology, Orthopedics, Gastroenterology, Pediatrics, Nephrology, Internal Medicine.

Price Movement & Share Holding

Today's High/Low

39.340.6

52 Week High/Low

3968.75
Past Returns

1 week

1.25%

1 month

-2.45%

3 month

-18.12%

1 year

-39.84%

3 year

-46.7%

5 year

-33.82%

Share Holding

Promoters

62.71%

FII

0%

DII

0.07%

Retail

31.51%

Others

5.71%

Company Overview

Founded Year

1989

Listed Year

-

Headquarter

Chennai, India

MD/CEO

Dr. K M Cherian

Website

http://www.fortismalarhospital.com

Price Movement & Share Holding

Today's High/Low

39.340.6

52 Week High/Low

3968.75

Past Returns

1 week

1.25%

1 month

-2.45%

3 month

-18.12%

1 year

-39.84%

3 year

-46.7%

5 year

-33.82%

Share Holding

Promoters

62.71%

FII

0%

DII

0.07%

Retail

31.51%

Others

5.71%

Company Facts

What we do

Fortis Malar Hospitals Ltd operated a multi-specialty hospital in Chennai, providing premium healthcare services in cardiology, neurology, and other specialities until sale of operations in 2024.

Founded in

1989

Market share

Recognized as one of the largest corporate hospitals in Chennai with significant presence in cardiac and tertiary care markets.

Problem solved

Addressed critical healthcare needs including cardiac surgeries, neuro surgery, orthopedics and multi-specialty medical care.

Top clients or who we serve

Served diverse patient base requiring multi-specialty hospital services across individual patients and referring physicians (B2C).

Key management

Dr. K M Cherian, renowned cardiac surgeon and Padmashree awardee, led Cardio Thoracic services.

Our journey and innovations

Established in 1989; pioneered open heart surgeries since 2003; expanded capacity and services; sold hospital operations in 2024.

Where we operate

Operated primarily in Chennai, Tamil Nadu, India.

Top products or what we offer

Hospital services in Cardiology, Neuro Surgery, Gynecology, Orthopedics, Gastroenterology, Pediatrics, Nephrology, Internal Medicine.

Top brands

Fortis Malar Hospital: #1 multi-specialty hospital in Chennai, key revenue driver till 2024.

Recurring vs cyclical contribution

Revenues were largely service-based and recurring through patient treatments until operations ceased.

Our industry position

Strong leader in Chennai's healthcare market with specialty focus; ceased operations in 2024 post asset sale.

Financial highlights

FY 2024-25 consolidated revenue stood near zero post sale; prior year revenue Rs. 59 crore; FY25 profit Rs. 0.39 crore after exceptional items.

Geographical revenue split

Revenue primarily from Chennai region, India.

Whats driving growth

Earlier growth driven by specialty healthcare demand and pioneering surgeries; no current operations post divestment.

Our future plans

Evaluating corporate restructuring and no current visibility of new business operations.

Our people and values

Previously employed healthcare professionals; no employees as on March 31, 2025 post divestment.

Key challenges ahead

Transitioned from active operations; main challenges include restructuring and future business strategy development.

Interesting facts

Performed 26,200 cardio thoracic surgeries under Dr. K M Cherian including transplants; hospital operated over 35 years.

Risks and strategy

Risks relate to corporate restructuring post divestment; strategy focuses on asset management and shareholder returns.

Market Footprint

Top Clients

Top Clients

Served diverse patient base requiring multi-specialty hospital services across individual patients and referring physicians (B2C).

Top Products

Top Products

Hospital services in Cardiology, Neuro Surgery, Gynecology, Orthopedics, Gastroenterology, Pediatrics, Nephrology, Internal Medicine.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions